In silico identification and biological evaluation of newly synthetic hinokiflavone derivatives as multi-kinase inhibitors with preferential Aurora A activity for ovarian cancer therapy.

Wang K, Chen GY, Chu PY, Pan YC, Hsu WY, Dai YH, Yang YL, Jang YJ, Wu YC

Open source

DOI
10.1016/j.ejmech.2026.119278
Published
2026 Aug 27
Container
European journal of medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejmech.2026.119278,
  title = {In silico identification and biological evaluation of newly synthetic hinokiflavone derivatives as multi-kinase inhibitors with preferential Aurora A activity for ovarian cancer therapy.},
  author = {Wang K and Chen GY and Chu PY and Pan YC and Hsu WY and Dai YH and Yang YL and Jang YJ and Wu YC},
  year = {2026},
  journal = {European journal of medicinal chemistry},
  doi = {10.1016/j.ejmech.2026.119278},
  url = {https://doi.org/10.1016/j.ejmech.2026.119278}
}

RIS

TY  - JOUR
TI  - In silico identification and biological evaluation of newly synthetic hinokiflavone derivatives as multi-kinase inhibitors with preferential Aurora A activity for ovarian cancer therapy.
AU  - Wang K
AU  - Chen GY
AU  - Chu PY
AU  - Pan YC
AU  - Hsu WY
AU  - Dai YH
AU  - Yang YL
AU  - Jang YJ
AU  - Wu YC
PY  - 2026
JO  - European journal of medicinal chemistry
DO  - 10.1016/j.ejmech.2026.119278
UR  - https://doi.org/10.1016/j.ejmech.2026.119278
ER  - 

APA

K, W., GY, C., PY, C., YC, P., WY, H., YH, D., YL, Y., YJ, J., & YC, W. (2026). In silico identification and biological evaluation of newly synthetic hinokiflavone derivatives as multi-kinase inhibitors with preferential Aurora A activity for ovarian cancer therapy.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.119278

Source records